Siblero, Glory Jean P.
HRN: 23-12-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/28/2023
06/04/2023
IV DRIP
1g
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes